INVO Fertility, Inc. splits its revenue into 6 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Clinic Revenue at $6.7 million, 98% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8
|
7
|
7
|
3
|
1
|
4
|
1
|
1
|
0
|
0
|
0
|
| Clinic Revenue |
7
+13.1%
share 98.5%
|
7
+4.2%
share 98.2%
|
6
+125.3%
share 98.8%
|
3
+365.6%
share 94.8%
|
1
+1305.5%
share 74.8%
|
0
share 1.1%
|
—
|
—
|
—
|
—
|
—
|
| Revenue From External Customers |
—
|
—
|
6
+125.3%
share 98.8%
|
3
share 94.8%
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| License Revenue |
—
|
—
|
—
|
—
|
—
|
4
+400.0%
share 85.8%
|
1
share 68.9%
|
—
|
—
|
—
|
—
|
| Product Revenue |
—
|
—
|
—
|
—
|
—
|
1
+68.7%
share 13.1%
|
0
share 31.1%
|
—
|
—
|
—
|
—
|
| Product |
0
+86.4%
share 1.5%
|
0
+47.4%
share 1.8%
|
0
-48.4%
share 1.2%
|
0
-23.8%
share 5.2%
|
0
share 25.2%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Inter Segment Revenue |
—
|
—
|
0
share 0.4%
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IVF (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Sarasota, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1417926
- Former names
- NAYA Biosciences, Inc. (until Apr 14, 2025); INVO Bioscience, Inc. (until Oct 15, 2024); EMY'S SALSA AJI DISTRIBUTION COMPANY, INC. (until Jan 5, 2009)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.